期刊文献+

探析子宫肌瘤剔除术后残留和复发的临床危险原因 被引量:3

下载PDF
导出
摘要 目的探讨子宫肌瘤剔除术后残留与复发的危险因素。方法将我院2010-01~2014-01间收治的123例子宫剔除术患者作为研究对象,对其临床资料进行回顾性分析,探讨术后残留与复发危险因素。结果肌瘤多发、肌瘤生长于肌壁间、术中发现存在肌瘤直径〈1 cm、采用经腹手术的患者行子宫剔除术术后残留或复发率更高(P〈0.05)。年龄、最大肌瘤直径、富于细胞型肌瘤不是残留、复发高危因素。结论肌瘤数目、肌壁间肌瘤、肌瘤直径〈1 cm是子宫肌瘤剔除术后残留或复发主要危险因素。
机构地区 东莞市人民医院
出处 《黑龙江医学》 2015年第8期950-951,共2页 Heilongjiang Medical Journal
  • 相关文献

参考文献7

二级参考文献21

  • 1Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas : a review [J]. Environ Health Perspect, 2003,111 ( 8 ) : 1037 - 1054.
  • 2Hanafi M. Predictors of leiomyoma recurrence after myomectomy[J]. Obstet Gynecol,2005,105(4) :877 -881.
  • 3Fauconnier A,Chapron C, Babaki-Fard K,et al. Recurrence of leiomyomata after myomeetomy[ J]. Hum Reprod Update,2000,6 ( 6 ) : 595 - 602.
  • 4Lumbiganon P,Rugpao S, Phandhu-fung S, et al, Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas:a muhicentre case control study [ J ]. Br J Obstet Gynaecol, 1996,103(9) :909-914.
  • 5Parazzini F, La Vecchia C,Negri E,et al. Epidemiologic characteristics of women with uterine fibroids: a case-control study[J]. Obstet Gynecol, 1988,72 ( 6 ) :853 - 857.
  • 6Parazzini F, Negri E, La Vecchia C, et al. Reproductive factors and risk of uterine fibroids[J]. Epidemiology, 1996, 7(5) : 440 - 442.
  • 7Fedele L, Parazzini F, Luchini L, et al. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study [J]. Hum Reprod, 1995,10 ( 7 ) : 1795 - 1796.
  • 8Solomon LA, Schimp VL, Ali-Fehmi R, et al. Clinical update of smooth muscle tumors of the uterus[J]. J Minim Invasive Gynecol, 2005,12:401-408.
  • 9Chang CC, Chen WA. A comparison of surgical outcomes between laparoscopic and open myomectomy in Southern Taiwan[J]. Int J Gynaecol Obstet, 2012,119:189-193.
  • 10Verkauf BS. Myomeetomy for fertility enhancement and preservation[J]. Fertil Steril, 1992,58:1-15.

共引文献1550

同被引文献48

  • 1Volker NA, Hehenkamp WJ, Smit P, et a/.Economic evalu- ation of uterine artery embolization versus hysterctomy in the treatment of symptomatic uterine fibroids:results from the randomized EMMY trial [J].J Vasc Interven Radiol, 2006,19(7) : 1007-1016.
  • 2Markowski DN, Bartnitzke S, L ning T.MED 12 mutations in uterinefibroids-their relationship to cytogenetic sub- groups[J].Int J Cancer, 2012,131 (7) : 1528-1536.
  • 3Mkinen N, Vahteristo P, Btitzow R,et a/.Exomie landscape of MED12 mutation-negative and -positive uterine leiomy- oma[J].Int J Cancer, 2014,133(4) : 1008-1012.
  • 4Shaik NA, Lone WG, Khan IA.Deteetion of somatic muta- tions and germline polymorphismsin mitochondrial DNA of uterine fibroids patients [J].Genet Test Mol Biomarker, 2011,15(7/8) :537-541.
  • 5Sabry M,A1-Hendy A.Medieal treatment of uterine leiomy- oma[Jl.Reorod Sci, 2012,19(4) : 339-353.
  • 6Dorenberg E J, Hol PK, Jakobsen JA,et a/.Improved infarc- tionrates in fibroids after the introduction of contrast- enhanced ultrasound during uterine artery embolization[J]. Acta Radiologica, 2012,53 ( 1 ) : 34-38.
  • 7Drazancic A.Antenatal care in developed countries--what should be done?[J].J Perinat Med, 2001,29 (3) : 188-192.
  • 8Bozzini N,Rodrigues CJ,Petti DA,et a/. Effects of treat- ment with gonadotropin releasing hormone agonist on the uterine leiomyomata structure [J].Acta Obstet Gynecol Scand, 2003,82(4) : 330-334.
  • 9Scialli AR,Jestila KJ. Sustained benefits of leuprolide ac- etate with or without subsequent medroxyprogesterone ac- etate in the nonsurgical management of leiomyomata u- teri[J].Fertil Steril, 1995,64(2) : 313-320.
  • 10Machado RB,de Souza IM,Beltrame A,et al. The lev- onorgestrel-releasing intrauterine system:its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids[J].Gynecol Endocrinol,2013, 29(5) :492-495.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部